MYLAN 1570 MYLAN 1570 (Terazosin Hydrochloride 10 mg)
Pill with imprint MYLAN 1570 MYLAN 1570 is Purple, Capsule-shape and has been identified as Terazosin Hydrochloride 10 mg. It is supplied by Mylan Pharmaceuticals Inc..
Terazosin is used in the treatment of benign prostatic hyperplasia; high blood pressure and belongs to the drug class antiadrenergic agents, peripherally acting. Risk cannot be ruled out during pregnancy. Terazosin 10 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for MYLAN 1570 MYLAN 1570
- MYLAN 1570 MYLAN 1570
- 10 mg
- 14.00 mm
- Prescription only
- Drug Class
- Antiadrenergic agents, peripherally acting
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Mylan Pharmaceuticals Inc.
- Inactive Ingredients
lactose anhydrous, silicon dioxide, D&C Red No. 28, D&C Red No. 33, FD&C Blue No. 1, magnesium stearate, microcrystalline cellulose, corn starch, sodium lauryl sulfate, titanium dioxide, ferrosoferric oxide, D&C Yellow No. 10, FD&C Blue No. 2, FD&C Red No. 40, propylene glycol, shellac
Note: Inactive ingredients may vary.
Labelers / Repackagers
|NDC Code||Labeler / Repackager|
|00378-1570||Mylan Pharmaceuticals Inc.|
|54569-4876||A-S Medication Solutions, LLC (repackager)|
More about terazosin
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 39 Reviews
- Drug class: antiadrenergic agents, peripherally acting
- FDA Alerts (1)
Other brands: Hytrin
Related treatment guides
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.